Insurers, Lawmakers Criticize Gilead and Abbvie for Overpriced Hep-C Drugs

January 10, 2015 12:08 PM

6 0

Insurers, Lawmakers Criticize Gilead and Abbvie for Overpriced Hep-C Drugs

AbbVie and Gilead Sciences, the only hepatitis C drug makers, have started offering consistent discounts on their products to health insurance providers across the US.

However, both the companies said the previous year that they were not planning to get involved in a price war in 2015.

Also read: Unilever shares slide after Kraft Heinz yanks $143B bid

Read more

To category page

Loading...